Skip to Content

GE's Breakup One of the Catalysts We've Been Hoping For

We maintain our fair value estimate for General Electric following the news that the conglomerate will separate into three public companies.

We maintain our discounted cash flow-derived fair value estimate of $131 per share for General Electric GE following the news that the conglomerate will separate into three public companies. We think this news is an important catalyst that will help close the persistent price/value gap for the stock, second only to the company hitting its target of high-single-digit free cash flow margin by 2023, which we think is tantamount to the GE story. Nonetheless, investors should cheer the news that management has committed to this target by 2023, as opposed to "2023-plus," as it had previously communicated. Additionally, investors will now have the opportunity to own either or both exceptional franchises in aviation and healthcare without having to hold on to GE's more challenged businesses. GE's plan is a much-needed audible from the prior broad portfolio construct first contemplated by CEO Larry Culp's predecessor, John Flannery, in June 2018. Culp pulled one audible when he scrapped that plan in favor of the painful but necessary decision to sell biopharma to Danaher. The Nov. 9 announcement represents the second such audible. While this was certainly on our radar of possibilities, we thought the plan would more likely be to only spin off what remains of GE Healthcare (mostly due to continued rumors in the press, Culp's prior comments, and because such a move was most like Flannery's prior plan). However, this would have left GE shareholders with one great but currently challenged wide-moat franchise in GE Aviation with two no-moat turnaround stories in GE Renewable Energy and GE Power. We think this situation would have been less than ideal, and we would have preferred GE hold on to healthcare, had it chosen to remain a multi-industry conglomerate.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

More in Stocks

About the Author

Joshua Aguilar

Director of Equity Research, Resources
More from Author

Joshua Aguilar is the director of resources equity research for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc.

Aguilar joined Morningstar in 2016 as an associate on the financials team, and he was promoted to analyst on the industrials team in 2018 and to senior analyst in 2022. He has served as associates coordinator since 2021 and led Morningstar's diversity efforts as DEI co-chair since 2020. Aguilar has been a mentor to several associates on their paths to becoming analysts. He also has hosted a Morningstar earnings town hall, participated in analyzing Morningstar stock, and been a strong contributor through both client interactions and his General Electric stock call. Aguilar co-authored an Outstanding Research Achievement-winning piece with colleague Kris Inton on CEO compensation in 2021. He also has taught Morningstar's model to new hires for many years as part of the valuation committee.

Before joining Morningstar, Aguilar was a practicing business transactional attorney in Florida. He graduated magna cum laude with a bachelor's degree in political science and criminology from the University of Florida. He also has a Master of Business Administration from Rollins College and a Juris Doctor from Wake Forest University.

Sponsor Center